PMC:6141714 / 6179-6718 JSONTXT

{"project":"MyTest","denotations":[{"id":"30254638-26794657-35420655","span":{"begin":43,"end":45},"obj":"26794657"},{"id":"30254638-28581352-35420656","span":{"begin":150,"end":152},"obj":"28581352"},{"id":"30254638-24561556-35420657","span":{"begin":311,"end":313},"obj":"24561556"},{"id":"30254638-1870029-35420658","span":{"begin":403,"end":405},"obj":"1870029"},{"id":"30254638-12147742-35420659","span":{"begin":407,"end":409},"obj":"12147742"},{"id":"30254638-15579650-35420659","span":{"begin":407,"end":409},"obj":"15579650"},{"id":"30254638-18816169-35420659","span":{"begin":407,"end":409},"obj":"18816169"},{"id":"30254638-12475952-35420659","span":{"begin":407,"end":409},"obj":"12475952"},{"id":"30254638-26118469-35420660","span":{"begin":467,"end":469},"obj":"26118469"},{"id":"30254638-28232595-35420661","span":{"begin":489,"end":491},"obj":"28232595"},{"id":"30254638-27809910-35420662","span":{"begin":535,"end":537},"obj":"27809910"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Positive results from pre-clinical trials (28) and the demonstration of immunomodulatory effects of mesenchymal stem cells in “in vitro” experiments (29) led to a rapid increase in interest for the therapeutic potential of the administration of these cells for the treatment of several immune-related diseases (20). As a consequence, it is currently possible to isolate hMSCs from a variety of tissues (12, 14–17), expand them in culture and administer them locally (30) or intravenously (31) for treatment of immune-related diseases (32)."}

{"project":"2_test","denotations":[{"id":"30254638-26794657-35420655","span":{"begin":43,"end":45},"obj":"26794657"},{"id":"30254638-28581352-35420656","span":{"begin":150,"end":152},"obj":"28581352"},{"id":"30254638-24561556-35420657","span":{"begin":311,"end":313},"obj":"24561556"},{"id":"30254638-1870029-35420658","span":{"begin":403,"end":405},"obj":"1870029"},{"id":"30254638-12147742-35420659","span":{"begin":407,"end":409},"obj":"12147742"},{"id":"30254638-15579650-35420659","span":{"begin":407,"end":409},"obj":"15579650"},{"id":"30254638-18816169-35420659","span":{"begin":407,"end":409},"obj":"18816169"},{"id":"30254638-12475952-35420659","span":{"begin":407,"end":409},"obj":"12475952"},{"id":"30254638-26118469-35420660","span":{"begin":467,"end":469},"obj":"26118469"},{"id":"30254638-28232595-35420661","span":{"begin":489,"end":491},"obj":"28232595"},{"id":"30254638-27809910-35420662","span":{"begin":535,"end":537},"obj":"27809910"}],"text":"Positive results from pre-clinical trials (28) and the demonstration of immunomodulatory effects of mesenchymal stem cells in “in vitro” experiments (29) led to a rapid increase in interest for the therapeutic potential of the administration of these cells for the treatment of several immune-related diseases (20). As a consequence, it is currently possible to isolate hMSCs from a variety of tissues (12, 14–17), expand them in culture and administer them locally (30) or intravenously (31) for treatment of immune-related diseases (32)."}